Teva Pharmaceutical is not allowed to start selling generic version of Aricept Anti Alzhimer’s drug. Teva had file PIV ANDA for launching generic version of Eisai’s product Aricept.
According to Bloomberg, Eisai’s biggest product with $2.16 billion in worldwide sales in the year ended in march 2007.
The case is Eisai Co. v. Teva Pharmaceuticals USA Inc., 05cv5727 and 07cv5489, U.S. District Court for the District of New Jersey (Newark).
To read full story: http://www.bloomberg.com/apps/news?pid=20601101&sid=a_oB7QDoTda0&refer=japan